0001213900-20-035129.txt : 20201104 0001213900-20-035129.hdr.sgml : 20201104 20201104212020 ACCESSION NUMBER: 0001213900-20-035129 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201102 FILED AS OF DATE: 20201104 DATE AS OF CHANGE: 20201104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shabahang Shahrokh CENTRAL INDEX KEY: 0001816754 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39336 FILM NUMBER: 201288382 MAIL ADDRESS: STREET 1: 11161 ANDERSON STREET STREET 2: SUITE 105-10014 CITY: LOMA LINDA STATE: CA ZIP: 92354 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ADiTx Therapeutics, Inc. CENTRAL INDEX KEY: 0001726711 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 823204328 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11161 ANDERSON STREET STREET 2: SUITE 105-10014 CITY: LOMA LINDA STATE: CA ZIP: 92354 BUSINESS PHONE: 909-488-0844 MAIL ADDRESS: STREET 1: 11161 ANDERSON STREET STREET 2: SUITE 105-10014 CITY: LOMA LINDA STATE: CA ZIP: 92354 4 1 ownership.xml X0306 4 2020-11-02 0 0001726711 ADiTx Therapeutics, Inc. ADTX 0001816754 Shabahang Shahrokh C/O ADITX THERAPEUTICS, INC. 11161 ANDERSON STREET, SUITE 105-10014 LOMA LINDA CA 92354 1 1 0 0 CHIEF INNOVATION OFFICER Stock Option (Right to Buy) 1.92 2020-11-02 4 A 0 110000 0 A 2030-11-02 Common Stock 110000 110000 D The options shall vest as to 50% of the total shares on November 2, 2021, after which the remaining 50% of the total shares shall vest in four successive equal quarterly installments. /s/ Shahrokh Shabahang 2020-11-04